CCMU
CNST

Cheyne Capital Management (UK)’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Cheyne Capital Management (UK)’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-58,688
Closed -$1.37M – 142
2021
Q1 		$1.37M Sell
58,688
-1,912
-3% -$57.9K 0.87% 40
2020
Q4 		$1.75M Sell
60,600
-30,250
-33% -$761K 0.88% 36
2020
Q3 		$1.84M Buy
+90,850
New +$2.22M 0.91% 35

Other funds holding CNST

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
OPU
Omni Partners US Irvine, California $1.95B AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
PIM
Ponoi II Management San Francisco, California $38.3M AUM 32.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cheyne Capital Management (UK)'s CNST Position: Q2 2021 in Review

Cheyne Capital Management (UK) sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q2 2021, closing a stake of 58,688 shares — an estimated $1.37M sold.

Cheyne Capital Management (UK) first reported a position in CNST in Q3 2020 and held it in 3 quarters. The position peaked at $1.84M in Q3 2020. 153 funds tracked by Wall St. Rank hold CNST as of Q2 2021.

  • Cheyne Capital Management (UK) reported no remaining Constellation Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 58,688 Constellation Pharmaceuticals, Inc. shares in Q2 2021, an estimated $1.37M.
  • Cheyne Capital Management (UK) first reported a position in Constellation Pharmaceuticals, Inc. in Q3 2020 and held it in 3 quarters.
  • Cheyne Capital Management (UK)'s Constellation Pharmaceuticals, Inc. position peaked at $1.84M in Q3 2020.
  • 153 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q2 2021.

Based on Cheyne Capital Management (UK)'s 13F filing for Q2 2021, filed 12 Aug 2021.